Moderate riskFDA DrugClass II

Meitheal Cetrorelix Acetate injection kit recalled for missing or duplicated needles

Meitheal Pharmaceuticals is recalling Cetrorelix Acetate 0.25 mg injection kits because some contain missing or duplicated needles in the delivery system. This affects lot Q4E0112A with an expiration date of April 30, 2027. The defect could prevent proper injection or cause unsafe handling.

From the FDA notice · Read the official notice ↗

What to do

  1. Check if you have lot Q4E0112A (expiration April 30, 2027)
  2. Stop using affected kits immediately
  3. Contact your pharmacy or healthcare provider for a replacement
  4. Do not attempt to use a kit with missing or extra needles

Is yours affected?

Compare your label or packaging with the recalled product.

Product
Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90.
Sold in
Nationwide
Made for
Adults (0 months and older)

Details

Units affected
16,477 kits
Illnesses reported
None reported
Manufactured in
8700 W Bryn Mawr Ave Ste 600s, N/A, Chicago, IL, United States
Classification
Class II
Recall number
D-0340-2026

In the FDA's words

Description
Cetrorelix Acetate for Injection (Kit), 0.25 mg per vial, Single-Dose Kit, Rx Only, Mfd. for: Meitheal Pharmaceuticals, Chicago, IL NDC 71288-558-90. Defective Delivery System: Missing or duplicated needles within the injection kit Lot Q4E0112A, Exp.: 30 Apr 2027 Distribution: U.S. Nationwide Affected quantity: 16,477 kits
Hazard
Defective Delivery System: Missing or duplicated needles within the injection kit

More from Meitheal Pharmaceuticals

Related topics

OtherParticulateDrugsSold nationwideMore from FDA Drug